Avalo Therapeutics, Inc. · NASDAQ:AVTX

Nantahala Capital Management, LLC reported a 9.39% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Nantahala Capital Management, LLC reported a 9.39% stake in Avalo Therapeutics, Inc., 1,235,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
9.39%
Shares
1,235,000
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Nantahala Capital Management, LLC9.39%1,235,000
Wilmot B. Harkey9.39%1,235,000
Daniel Mack9.39%1,235,000

Source

View original at SEC

Related